Abstract
We present the Consensus Induced Fit Docking (cIFD) approach for adapting a protein binding site to accommodate multiple diverse ligands for virtual screening. This novel approach results in a single binding site structure that can bind diverse chemotypes and is thus highly useful for efficient structure-based virtual screening. We first describe the cIFD method and its validation on three targets that were previously shown to be challenging for docking programs (COX-2, estrogen receptor, and HIV reverse transcriptase). We then demonstrate the application of cIFD to the challenging discovery of irreversible Crm1 inhibitors. We report the identification of 33 novel Crm1 inhibitors, which resulted from the testing of 402 purchased compounds selected from a screening set containing 261,680 compounds. This corresponds to a hit rate of 8.2 %. The novel Crm1 inhibitors reveal diverse chemical structures, validating the utility of the cIFD method in a real-world drug discovery project. This approach offers a pragmatic way to implicitly account for protein flexibility without the additional computational costs of ensemble docking or including full protein flexibility during virtual screening.





Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Tsou CL (1993) Science 262(5132):380
Teague SJ (2003) Nat Rev Drug Disc 2(7):527
Carlson HA, McCammon JA (2000) Mol Pharmacol 57(2):213
Carlson HA (2002) Curr Opin Chem Biol 6(4):447
Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT (2006) J Med Chem 49(21):6177
Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL (2004) J Med Chem 47(7):1750
Shoichet BK (2004) Nature 432(7019):862
Shen J, Tan C, Zhang Y, Li X, Li W, Huang J, Shen X, Tang Y (2010) J Med Chem 53(14):5361
Podvinec M, Lim SP, Schmidt T, Scarsi M, Wen D, Sonntag L-S, Sanschagrin P, Shenkin PS, Schwede T (2010) J Med Chem 53(4):1483
Huggins DJ, Sherman W, Tidor B (2012) J Med Chem 55(4):1424
Shan Y, Kim E, Eastwood MP, Dror RO, Seeliger MA, Shaw DE (2011) J Am Chem Soc 133(24):9181
Gervasio FL, Laio A, Parrinello M (2005) J Am Chem Soc 127(8):2600
Sherman W, Beard HS, Farid R (2006) Chem Biol Drug Des 67(1):83
Huang SY, Zou X (2007) Proteins: Struct, Funct, Bioinf 66(2):399
Rao S, Sanschagrin PC, Greenwood JR, Repasky MP, Sherman W, Farid R (2008) J Comput Aided Mol Des 22(9):621
Barril X, Morley SD (2005) J Med Chem 48(13):4432
Craig IR, Essex JW, Spiegel K (2010) J Chem Inf Model 50(4):511
Bouzida D, Rejto PA, Arthurs S, Colson AB, Freer ST, Gehlhaar DK, Larson V, Luty BA, Rose PW, Verkhivker GM (1999) Int J Quantum Chem 72(1):73
Rueda M, Bottegoni G, Abagyan R (2009) J Chem Inf Model 49(3):716
Cavasotto CN, Kovacs JA, Abagyan RA (2005) J Am Chem Soc 127(26):9632
Nichols SE, Baron R, Ivetac A, McCammon JA (2011) J Chem Inf Model 51(6):1439
Osguthorpe DJ, Sherman W, Hagler AT (2012) J Phys Chem B 116(23):6952
Osguthorpe DJ, Sherman W, Hagler AT (2012) Chem Biol Drug Des 80(2):182
Corbeil CR, Englebienne P, Yannopoulos CG, Chan L, Das SK, Bilimoria D, L’Heureux L, Moitessier N (2008) J Chem Inf Model 48(4):902
Cavasotto CN, Abagyan RA (2004) J Mol Biol 337(1):209
Sela I, Golan G, Strajbl M, Rivenzon-Segal D, Bar-Haim S, Bloch I, Inbal B, Shitrit A, Ben-Zeev E, Fichman M, Markus Y, Marantz Y, Senderowitz H, Kalid O (2010) Curr Top Med Chem 10(6):638
Roitberg A, Elber R (1991) J Chem Phys 95:9277
Sherman W, Day T, Jacobson MP, Friesner RA, Farid R (2006) J Med Chem 49(2):534
Kutay U, Güttinger S (2005) Trends Cell Biol 15(3):121
Turner JG, Sullivan DM (2008) Curr Med Chem 15(26):2648
Mutka SC, Yang WQ, Dong SD, Ward SL, Craig DA, Timmermans PBMWM, Murli S (2009) Cancer Res 69(2):510
Köster M, Lykke-Andersen S, Elnakady YA, Gerth K, Washausen P, Höfle G, Sasse F, Kjems J, Hauser H (2003) Exp Cell Res 286(2):321
Meissner T, Krause E, Vinkemeier U (2004) FEBS Lett 576(1):27
Bonazzi S, Eidam O, Güttinger S, Wach J-Y, Zemp I, Kutay U, Gademann K (2010) J Am Chem Soc 132(4):1432
Kau TR, Schroeder F, Ramaswamy S, Wojciechowski CL, Zhao JJ, Roberts TM, Clardy J, Sellers WR, Silver PA (2003) Cancer Cell 4(6):463
Van Neck T, Pannecouque C, Vanstreels E, Stevens M, Dehaen W, Daelemans D (2008) Bioorg Med Chem 16(21):9487
Shacham S, Kauffman M, Sandanayaka VP, Shechter S, US 2011/0275607 A1 (2011) Nuclear transport modulators and uses thereof. Google Patents
Sakakibara K, Saito N, Sato T, Suzuki A, Hasegawa Y, Friedman JM, Kufe DW, VonHoff DD, Iwami T, Kawabe T (2011) Blood 118(14):3922
McGaughey GB, Sheridan RP, Bayly CI, Culberson JC, Kreatsoulas C, Lindsley S, Maiorov V, Truchon J-F, Cornell WD (2007) J Chem Inf Model 47(4):1504
Kurumbail RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY, Gildehaus D, iyashiro JM, Penning TD, Seibert K, Isakson PC, Stallings WC (1996) Nature 384(6610):644
Kiefer JR, Pawlitz JL, Moreland KT, Stegeman RA, Hood WF, Gierse JK, Stevens AM, Goodwin DC, Rowlinson SW, Marnett LJ, Stallings WC, Kurumbail RG (2000) Nature 405(6782):97
Wang JL, Limburg D, Graneto MJ, Springer J, Hamper JRB, Liao S, Pawlitz JL, Kurumbail RG, Maziasz T, Talley JJ, Kiefer JR, Carter J (2010) Bioorg Med Chem Lett 20(23):7159
Canvas v1.4. (2011) Schrödinger Inc., Portland
Sastry M, Lowrie JF, Dixon SL, Sherman W (2010) J Chem Inf Model 50(5):771
Das K, Lewi PJ, Hughes SH, Arnold E (2005) Prog Biophys Mol Biol 88(2):209
Hopkins AL, Ren J, Milton J, Hazen RJ, Chan JH, Stuart DI, Stammers DK (2004) J Med Chem 47(24):5912
Pargellis C, Tong L, Churchill L, Cirillo PF, Gilmore T, Graham AG, Grob PM, Hickey ER, Moss N, Pav S (2002) Nat Struct Mol Biol 9(4):268
Etchin J, Sun Q, Kentsis A, Farmer A, Zhang Z, Sanda T, Mansour M, Barcelo C, McCauley D, Kauffman M (2012) Leukemia. doi:10.1038/leu.2012.219
Monecke T, Güttler T, Neumann P, Dickmanns A, Görlich D, Ficner R (2009) Science 324(5930):1087
Khanna IK, Weier RM, Yu Y, Xu XD, Koszyk FJ, Collins PW, Koboldt CM, Veenhuizen AW, Perkins WE, Casler JJ, Masferrer JL, Zhang YY, Gregory SA, Seibert K, Isakson PC (1997) J Med Chem 40(11):1634
Halgren T (2007) Chem Biol Drug Des 69(2):146
Halgren T (2009) J Chem Inf Model 49:377
Maestro v9.2. (2011) Schrödinger, Inc., Portland
LigPrep v2.4. (2010) Schrödinger Inc., Portland
Rogers D, Hahn M (2010) J Chem Inf Model 50(5):742
Butina D (1999) J Chem Inf Comput Sci 39(4):747
Prime v3.0. (2011) Schrödinger Inc., Portland
Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS (2004) J Med Chem 47(7):1739
Truchon J-F, Bayly CI (2007) J Chem Inf Model 47(2):488
Salam NK, Nuti R, Sherman W (2009) J Chem Inf Model 49(10):2356
Wang R, Lai L, Wang S (2002) J Comput Aided Mol Des 16(1):11
Sastry M, Dixon S, Sherman W (2011) J Chem Inf Model 51(10):2455
QikProp v2.0. (2011) Schrödinger Inc., Portland
Daylight Chemical Information Systems (2008) Aliso Viejo
Portevin B, Tordjman C, Pastoureau P, Bonnet J, De Nanteuil G (2000) J Med Chem 43(24):4582
Janusz JM, Young PA, Ridgeway JM, Scherz MW, Enzweiler K, Wu LI, Gan L, Chen J, Kellstein DE, Green SA, Tulich JL, Rosario-Jansen T, Magrisso IJ, Wehmeyer KR, Kuhlenbeck DL, Eichhold TH, Dobson RLM (1998) J Med Chem 41(18):3515
Huang H-C, Li JJ, Garland DJ, Chamberlain TS, Reinhard EJ, Manning RE, Seibert K, Koboldt CM, Gregory SA, Anderson GD, Veenhuizen AW, Zhang Y, Perkins WE, Burton EG, Cogburn JN, Isakson PC, Reitz DB (1996) J Med Chem 39(1):253
Motakis D, Parniak MA (2002) Antimicrob Agents Chemother 46(6):1851
Tanaka H, Takashima H, Ubasawa M, Sekiya K, Inouye N, Baba M, Shigeta S, Walker RT, De Clercq E, Miyasaka T (1995) J Med Chem 38(15):2860
Ludovici DW, Kavash RW, Kukla MJ, Ho CY, Ye H, De Corte BL, Andries K, de Béthune M-P, Azijn H, Pauwels R, Moereels HEL, Heeres J, Koymans LMH, de Jonge MR, Van Aken KJA, Daeyaert FFD, Lewi PJ, Das K, Arnold E, Janssen PAJ (2001) Bioorg Med Chem Lett 11(17):2229
Himmel DM, Das K, Clark AD, Hughes SH, Benjahad A, Oumouch S, Guillemont J, Coupa S, Poncelet A, Csoka I, Meyer C, Andries K, Nguyen CH, Grierson DS, Arnold E (2005) J Med Chem 48(24):7582
Sun J, Meyers MJ, Fink BE, Rajendran R, Katzenellenbogen JA, Katzenellenbogen BS (1999) Endocrinology 140(2):800
Gangloff M, Ruff M, Eiler S, Duclaud S, Wurtz JM, Moras D (2001) J Biol Chem 276(18):15059
Blizzard TA, DiNinno F, Morgan Ii JD, Chen HY, Wu JY, Kim S, Chan W, Birzin ET, Yang YT, Pai LY, Fitzgerald PMD, Sharma N, Li Y, Zhang Z, Hayes EC, DaSilva CA, Tang W, Rohrer SP, Schaeffer JM, Hammond ML (2005) Bioorg Med Chem Lett 15(1):107
Dykstra KD, Guo L, Birzin ET, Chan W, Yang YT, Hayes EC, DaSilva CA, Pai L-Y, Mosley RT, Kraker B, Fitzgerald PMD, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML (2007) Bioorg Med Chem Lett 17(8):2322
Richardson TI, Frank SA, Wang M, Clarke CA, Jones SA, Ying B-P, Kohlman DT, Wallace OB, Shepherd TA, Dally RD, Palkowitz AD, Geiser AG, Bryant HU, Henck JW, Cohen IR, Rudmann DG, McCann DJ, Coutant DE, Oldham SW, Hummel CW, Fong KC, Hinklin R, Lewis G, Tian H, Dodge JA (2007) Bioorg Med Chem Lett 17(13):3544
Author information
Authors and Affiliations
Corresponding author
Additional information
Ori Kalid, Dora Toledo Warshaviak: equal contributors.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kalid, O., Toledo Warshaviak, D., Shechter, S. et al. Consensus Induced Fit Docking (cIFD): methodology, validation, and application to the discovery of novel Crm1 inhibitors. J Comput Aided Mol Des 26, 1217–1228 (2012). https://doi.org/10.1007/s10822-012-9611-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-012-9611-9